Financial Data and Key Metrics Changes - For the second quarter, revenue increased slightly to $5,160,000 compared to $5,130,000 in the previous quarter, marking the sixth consecutive quarter of revenue over $5,000,000 [20][29] - Net income for the quarter increased 27% to $431,000 compared to $340,000 last year, reflecting higher gross profit and lower operating expenses [20][33] - For the first half of fiscal year 2026, total sales reached a record $10,300,000, up from $10,190,000 in the previous year, with net income increasing 36% to $917,000 [23][37] Business Line Data and Key Metrics Changes - Medical market sales increased by 150% year over year to $1,000,000, driven by balloon coating systems shipped to the U.S., Europe, and China [19][22] - Integrated Coatings Systems sales decreased by 24% to $1,530,000, primarily due to a customer-requested delivery delay [21] - OEM sales increased by 92% to $394,000, driven by strong shipments to Fluxer OEMs and new optics-related OEM wins [21] Market Data and Key Metrics Changes - U.S.-Canada sales decreased by 22% year over year, driven by slowing momentum in the clean energy industry [20] - Sales in Asia increased by 153% year over year, with major growth in China and other parts of Asia [20] - EMEA sales increased by 25%, while Latin America sales decreased by $74,000 [21] Company Strategy and Development Direction - The company has shifted to offering larger, more complex systems, which has broadened its addressable market and increased average unit selling prices [9][16] - The diversification strategy has shown momentum in the medical device industry, offsetting declines in clean energy orders [14][27] - Investments in R&D and application engineering are aimed at enhancing customer partnerships and driving long-term growth [64][66] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about future growth, supported by a solid backlog of $11,200,000 and a strong balance sheet with $10,600,000 in cash and no debt [15][26] - The company anticipates modest revenue growth for the full fiscal year, balancing caution with expected demand from the medical device industry [15][27] - Management noted that the clean energy sector is expected to decline this year, but diversification efforts are expected to mitigate this impact [14][27] Other Important Information - The company reported a gross profit margin increase to 50% for the second quarter, attributed to a favorable product mix and reduced costs [29][30] - The company has invested $1,300,000 in R&D for the first half of fiscal year 2026, compared to $1,400,000 in the previous year [26][34] - The company maintains a strong cash position with no outstanding debt, allowing for continued investment in growth initiatives [37] Q&A Session Summary Question: Insights on medical device strength and Chinese exposure - Management noted that despite challenges in the Chinese market, significant orders have been captured due to superior quality compared to local competitors [42][45] Question: Details on new optics-related OEMs - Management indicated that these new partnerships are significant for long-term market entry, although immediate revenue impact may be limited [76] Question: Semiconductor market outlook - Management reported strong interest from customers at a recent trade show, indicating potential growth in the semiconductor sector [79] Question: Backlog revenue recognition timeframe - The majority of recent large orders will be recognized in FY 2027, with some expected to ship in the current fiscal year [87] Question: Projections for second half sales - Management expects Q3 to be slightly higher than Q4 due to a system shipment delay [90]

Core Insights - Sono-Tek Corporation will hold a conference call on October 14, 2025, to discuss its fiscal second quarter and first half 2026 financial results, which ended on August 31, 2025 [1][2]. Company Overview - Sono-Tek Corporation is a global leader in the design and manufacture of ultrasonic coating systems, serving various industries such as microelectronics, alternative energy, medical devices, and advanced industrial manufacturing [5][6]. - The company is making significant advancements in the clean energy sector, particularly in next-generation solar cells, fuel cells, green hydrogen generation, and carbon capture applications [5]. Product and Market Strategy - Sono-Tek's product line is evolving from research and development to high-volume production machines, indicating a shift towards higher average selling prices and showcasing market leadership [6]. - The company employs a strategic distribution network that includes direct sales personnel, independent distributors, and experienced sales representatives to ensure efficient market reach across diverse sectors globally [6]. Environmental Impact - The solutions provided by Sono-Tek are environmentally friendly and efficient, leading to significant reductions in overspray, raw material usage, water and energy consumption, while improving process repeatability and reducing emissions [7]. Growth Strategy - Sono-Tek's growth strategy focuses on leveraging innovative technologies and proprietary know-how to enhance thin film coating technologies, aiming for better outcomes for customers' products and processes [8].

Core Insights - Sono-Tek Corporation reported a record revenue of $20.5 million for FY 2025, marking a 4% increase from $19.7 million in FY 2024, driven by strong demand in the Alternative/Clean Energy market [8][10][31] - The company has maintained a strong backlog of $8.6 million, indicating continued demand for its products [1][8] - The first half of FY 2026 is projected to see continued revenue growth and profitability, particularly in the medical device industry [2][4] Financial Performance - Net Sales for FY 2025 reached $20.5 million, up 4% from FY 2024 [10][28] - Gross Profit was $9.74 million, a slight decrease of 1% from the previous year, with a gross margin of 47.5%, down from 50% [8][10] - Operating Income decreased to $1.01 million, down 14.5% from $1.18 million in FY 2024 [10][28] - Net Income for FY 2025 was approximately $1.3 million, down from $1.4 million in FY 2024 [8][10] Market and Product Insights - The Alternative/Clean Energy market saw a significant increase of 64%, contributing $9.84 million to total sales [15][31] - The medical market experienced a decline of 22%, with sales dropping to $3.25 million [31] - The company is focusing on high average selling price (ASP) orders, which are expected to drive future growth [5][19] Geographic Performance - Sales in the U.S. and Canada increased by 15%, totaling $12.51 million [32] - Sales in the Asia Pacific region decreased by 16%, while sales in Europe, the Middle East, and Asia remained relatively stable with a 2% increase [32] Future Outlook - The company anticipates continued revenue growth and profitability in the first half of FY 2026, supported by a strong backlog and steady demand across key markets [4][9] - Visibility beyond the first half of FY 2026 is limited due to uncertainties regarding governmental clean energy incentives and evolving tariff policies [4][9]